Press Releases

2009

Dec-9-09	Cortex Receives Delisting Notification from NYSE Amex
Nov-16-09	Cortex Reports Third Quarter Operating Results
Sept-2-09	Cortex’s CEO to Present at Rodman & Renshaw’s Eleventh Annual Healthcare Conference on September 10, 2009
Aug-14-09	Cortex Reports Second Quarter Operating Results
July-30-09	Cortex Pharmaceuticals Announces Financing
June-1-09	Cortex Annual Shareholder Meeting Notification
May-22-09	Cortex Receives Notice of Non-Compliance From NYSE Amex For Continued Listing Requirements
May-15-09	Cortex Reports First Quarter Operating Results
Apr-20-09	Cortex Announces Closing of Financing
Apr-14-09	Cortex Announces Financing
Apr-14-09	Cortex Reports Fourth Quarter and Year End Operating Results
Mar-19-09	Cortex Pharmaceuticals Announces Corporate Restructuring and Workforce Reduction
Mar-6-09	Studies in Animals Demonstrate AMPAKINE Molecules Reverse Memory Loss in Huntington’s Disease
Feb-11-09	Cortex’s CEO to Present at the Roth Capital Partners 21st Annual Orange County Growth Stock Conference
Jan-27-09	Cortex Receives UK Regulatory Approval to Initiate a Clinical Study in Sleep Apnea with its AMPAKINE CX1739